Biomat is committed to offer Coronavirus COVID-19 Research Solution for: pathogen detection, vaccine development, and drug discovery.
Biomat is a worldwide manufacturer of Plates and Tubes for ELISA and PCR Assays Tests with leading expertise in surface modification.
A new Coronavirus (SARS-CoV-2) outbreak began in December 2019 in Wuhan, China and since then has been spreading globally very rapidly. The new Coronavirus disease has been called COVID-19 and is characterised by fever, loss of taste and smell, cough, and shortness of breath.
By now the COVID-19 Sequencing has been isolated in different parts of the world but researchers are still working to gain a better understanding of the COVID-19 to develop effective treatments and a possible vaccine.
Coronavirus (COVID-19) disease detection is currently done by molecular recognition through PCR Assay testing (polymerase chain reaction) using real-time reverse transcription polymerase chain reaction for diagnostic purposes.
Researchers are also already working on a ELISA Assays testing for the recognition of antibodies produced by the immune system against the virus.
Coronavirus COVID-19 Research Solution Commitment
We are glad to announce Biomat’s full commitment to work with companies and labs developing RT-PCR and ELISA Assay Kits to fight COVID-19 spread by offering the best prices on the market and giving our maximum support and collaboration.
We offer a wide array of products for research for RT-PCR and ELISA Assays and we believe the following will provide the best support for Coronavirus COVID-19 pathogen detection, vaccine development, and treatment discovery:
- Coated PCR Products: Streptavidin, HB streptavidin
- High Binding 96 Well ELISA Plates:
Don’t hesitate to contact us to discuss how we can fight together this battle.
To guarantee our commitment to Coronavirus COVID-19 Research Solution Biomat has developed a thorough business continuity plan to support your needs but also that we have implemented a strict protocol to guarantee the safety of our workers, partners, suppliers and their families.
- Supplier capacity assessment and identification supplier risks
- Development of an alternative supply plan
- Continuous monitoring of logistical status
- Transparent customer’s communication
Stakeholders Safety Protocol
After the outbreak in Italy Biomat has immediately developed a Safety Protocol to preserve the health of all its stakeholders (suppliers, employees, partners and customers).
- Thorough hygienisation of Biomat building and all its rooms
- No external visitor and no travel policy
- Development of an Employees Healthy Guidelines Manual for best practices guidance (minimum distancing, common area, personal hygenisation, rooms hygenization etc.)
- Employees signed an agreement with Biomat certifying their compliance to Government and Company guidelines
- On-site employees limitations to the ones directly involved in the production
- Smart-working was implemented for all other employees
- COVID-19 insurance integration coverage.
For more up-to-date information on the current coronavirus outbreak, visit the WHO websites.